British Journal of Clinical Pharmacology, 2013 K. Knights, A. Rowland, J. Miners
semanticscholar +1 more source
Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis. [PDF]
PLoS Negl Trop Dis, 2019 Flynn AF +9 more
europepmc +1 more source
Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: potential drug-drug interactions. [PDF]
Chin Med, 2020 Qin Z +7 more
europepmc +1 more source
Differential Role of Liver X Receptor (LXR) α and LXRβ in the Regulation of UDP-Glucuronosyltransferase 1A1 in Humanized UGT1 Mice. [PDF]
Drug Metab Dispos, 2020 Hansmann E +6 more
europepmc +1 more source
Backbone assignment of the apo-form of the human C-terminal domain of UDP-glucuronosyltransferase 1A (UGT1A). [PDF]
Biomol NMR Assign, 2018 Osborne MJ +3 more
europepmc +1 more source
Oligomerization and Catalytic Parameters of Human UDP-Glucuronosyltransferase 1A10: Expression and Characterization of the Recombinant Protein. [PDF]
Drug Metab Dispos, 2018 Kim K, Zheng F, Zhan CG.
europepmc +1 more source
In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters. [PDF]
Molecules, 2019 Kim S +8 more
europepmc +1 more source
Genetic Polymorphism of UDP-Glucuronosyltransferase
, 2017 Huma Mehboob +5 more
openaire +2 more sources